HepCBC Mission Statement

HepCBC is a non-profit organization run by and for people infected and affected by hepatitis C. Our mission is to provide education, prevention and support to those living with HCV.

Check out our new Aboriginal and Northern Communities Pamphlet

Hot Off The Press!

A promising Hep C program seems to be working — and it could be a model for other countries

Close to 8% of the Georgian population is living with hepatitis C, an infection that can lead to serious liver problems, including cancer. Georgia, a country nestled against the Black Sea between Turkey and Russia with a population of 3.7 million, has since taken on a public health effort to help reduce its prevalence of hepatitis C (HCV for short) by 90% by 2020. To make it happen, the US Centers for Disease Control and Prevention is working with Geor

Gilead Announces SVR12 Rates From Four Phase 3 Studies of a Once-Daily, Fixed-Dose Combination of Sofosbuvir, Velpatasvir and Voxilaprevir in Treatment-Naïve and Treatment-Experienced Genotype 1-6 Chronic HCV-Infected Patients

If Approved, SOF/VEL/VOX Would Be the First Once-Daily Single Tablet Regimen Available for Salvage for Patients Who Have Failed Prior HCV Therapy with Oral Direct-Acting Antiviral Agent Regimens.  U.S. NDA Planned for Q4 2016 FOSTER CITY, Calif.--(BUSINESS WIRE)--Oct. 20, 2016-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced topline results from four international Phase 3 clinical studies (POLARIS-1, POLARIS-2, POLARIS-3 and POLARIS-4) evaluating an

Coinfection with HIV-Hepatitis C Can Increase Cancer Risk

People who have HIV are at higher risk of getting lymphoma, about 100 times greater than the general population, a recent study suggests. Even after they get antiretroviral therapy, people who are HIV positive have a 10-fold higher risk of lymphoma. A new study from Europe found that having HIV, plus a hepatitis virus (B, C, or both), further adds to the risk of lymphoma, specifically non-Hodgkin’s lymphoma (NHL). But in a puzzling finding, the researc

Why Doctors Without Borders said no to 1 million free vaccines

Medical aid organization Doctors Without Borders says it would rather pay than accept a donation of one million pneumonia vaccine doses from pharmaceutical giant Pfizer. In an Oct. 12 blog post, the humanitarian organization’s executive director Jason Cone explained why they rejected Pfizer’s donation offer, saying the organization is trying to raise awareness on the issue of medical affordability for many nations around the world, where the cost of the v

The Week in Review: Oct 8 – Oct 14, 2016

Friday, October-14-16   News in Brief New Hepatitis C Pamphlets for Special Populations Released October 13, 2016 HepCBC has been working for some time on updating our pamphlet urging baby boomers (born 1945 - 1975) to get tested. Today we released not one but two versions of this updated pamphlet, both of which are FREE. For copies, send email to info@hepcbc.ca with your organization's name, mailing address, and number of copies desir...

Why are hepatitis C drugs priced so high? Click on the image BELOW to find out more!